Skip to main content
. 2021 Jun 19;61(4):1185–1192. doi: 10.47162/RJME.61.4.20

Figure 2.

Figure 2

Moderately active chronic hepatitis C, fibrosis. Anti-CD20 antibody immunostaining, ×200